HAIQU (Hospital AIr QUality)
ConditionAcute Respiratory Tract Infection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this research is to assess whether integration of an aerosol biosensor and air quality risk assessment software that integrates into a building management system will improve indoor air quality metrics in hospital environments and reduces risk factors associated with respiratory disease transmission.
Eligibility criteria
Qualifiers
Mayo Clinic Staff working in ED with a minimum of .7 FTE in Midwest (MN and WI), Phoenix (AZ), or Jacksonville (FL) and patient contact.
Mayo Clinic Staff working in primary care with a minimum of .7 FTE. in Rochester (MN), Phoenix (AZ), or Jacksonville (FL) and patient contact
Disqualifiers
Any participant who does not meet either of the inclusion criteria.
Trial design
Treatments tested in this trial
- Self-swab test
Treatment groups
850 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
Advanced Research Projects Agency for Health
Collaborator
Roche Pharma AG
Collaborator
Source ClinicalTrials.gov